Procter & Gamble Health Ltd manufactures Neurobion Forte Injection in GMP-certified facilities
Using unregulated "research chemical" products with unknown purity, incorrect concentrations, and potential contamination (bacterial endotoxins, heavy metals, residual solvents) introduces risks that have nothing to do with the peptide
If youre not deficient, routine injections are seldom necessary
doi:10.3390/ijms16011111 Buoli M, Grassi S, Serati M, Altamura AC
Over the next five years, well almost certainly have better human trials, clearer safety data and a much better understanding of where BPC-157 genuinely has a place in medicine and where it doesnt. That may ultimately prove to be the real story
When examining the effects of BPC 157 on tail spasticity the results reported that development of spasticity began earlier in the test subjects treated with the peptide in comparison to the corresponding controls